Choice of Unmanipulated T Cell Replete Graft for Haploidentical Stem Cell Transplant and Posttransplant Cyclophosphamide in Hematologic Malignancies in Adults: Peripheral Blood or Bone Marrow—Review of Published Literature
Allogeneic hematopoietic stem cell transplantation (SCT) is often the only curative option for many patients with malignant and benign hematological stem cell disorders. However, some issues are still of concern regarding finding a donor like shrinking family sizes in many societies, underrepresenta...
Saved in:
Main Authors: | Shatha Farhan, Edward Peres, Nalini Janakiraman |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Advances in Hematology |
Online Access: | http://dx.doi.org/10.1155/2016/6950346 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Phase II Trial of Melphalan Based Reduced-Intensity Conditioning for Transplantation of T-Replete HLA-Haploidentical Peripheral Blood Stem Cells with Posttransplant Cyclophosphamide in Patients with Hematologic Malignancies
by: Melhem M. Solh, et al.
Published: (2021-01-01) -
Haploidentical stem cell transplantation with posttransplant cyclophosphamide in children with Wiskott–Aldrich syndrome: a case report
by: Le Nguyen Ngoc Quynh, et al.
Published: (2025-02-01) -
Review on Haploidentical Hematopoietic Cell Transplantation in Patients with Hematologic Malignancies
by: William A. Fabricius, et al.
Published: (2016-01-01) -
HLA Haplotype Mismatch Transplants and Posttransplant Cyclophosphamide
by: Andrea Bacigalupo, et al.
Published: (2016-01-01) -
Chimerism in Myeloid Malignancies following Stem Cell Transplantation Using FluBu4 with and without Busulfan Pharmacokinetics versus BuCy
by: Shatha Farhan, et al.
Published: (2017-01-01)